FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41525811000001106: Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2910401000001119 Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2910421000001114 Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has AMP Abiraterone 250mg tablets (Cipla EU Ltd) true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Is a Abiraterone 250mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has specific active ingredient Abiraterone acetate true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets (Cipla EU Ltd) 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start